-
Loading metrics
Cenicriviroc, a Novel CCR5 (R5) and CCR2 Antagonist, Shows In Vitro Activity against R5 Tropic HIV-2 Clinical Isolates
- Benoit Visseaux,
- Charlotte Charpentier,
- Gilles Collin,
- Mélanie Bertine,
- Gilles Peytavin,
- Florence Damond,
- Sophie Matheron,
- Eric Lefebvre,
- Françoise Brun-Vézinet,
- Diane Descamps
x
- Published: August 6, 2015
- https://doi.org/10.1371/journal.pone.0134904